Analysts: GM Will Improve Throughout 2013 and 3 More Research Notes to Check Out

General Motors Co. (NYSE:GM): RBC Capital increased its target on GM to $45 from $41, as the firm believes the company reported solid second-quarter results. RBC now has more confidence that the company’s results will improve meaningfully in the second half of the year, and it keeps an Outperform rating.

gm

Boston Scientific (NYSE:BSX): RBC Capital expects Boston Scientific’s shares to be boosted by new product launches and continued cost cutting, and the firm keeps an Outperform rating on the shares.

bsx

Celgene (NASDAQ:CELG): Cantor has raised its price target on Celgene to $156 from $142 after the company reported stronger-than-expected results. The firm keeps a Buy rating on the shares.

celg

Whiting Petroleum (NYSE:WLL): Brean Capital has raised its price target on Whiting Petroleum to $75 from $67 following second-quarter results and expects improving well results from the company’s Bakken and Redtail Niobrara plays to drive share price appreciation. It has a Buy rating on the stock.

wll

Don’t Miss: 5 Premium Brands Making a Killing in the U.S. Car Market.